Mark J. Millan

Best Publications

• Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application.

  Mark J. Millan

  746
  Citations

• Differential Actions of Antiparkinson Agents at Multiple Classes of Monoaminergic Receptor. I. A Multivariate Analysis of the Binding Profiles of 14 Drugs at 21 Native and Cloned Human Receptor Subtypes

  Mark J. Millan;Lisa Maiofiss;Didier Cussac;Valérie Audinot

  628
  Citations

• Altering the course of schizophrenia: progress and perspectives

  Mark J. Millan;Annie Andrieux;George Bartzokis;Kristin Cadenhead

  599
  Citations

• Improving the Treatment of Schizophrenia: Focus on Serotonin (5-HT)1A Receptors

  Mark J. Millan

  434
  Citations

• Antinociceptive effects of mu- and kappa-agonists in inflammation are enhanced by a peripheral opioid receptor-specific mechanism.

  Christoph Stein;M.J. Millan;M.J. Millan;A. Yassouridis;A. Yassouridis;A. Herz;A. Herz

  287
  Citations

• Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a []GTPγS binding study

  Adrian Newman-Tancredi;Samantha Gavaudan;Caroline Conte;Christine Chaput

  283
  Citations

• Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT(1B), 5-HT(1D) and dopamine D(2) and D(3) receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states.

  Mark J. Millan;Adrian Newman‐Tancredi;Valérie Audinot;Didier Cussac

  266
  Citations

• The endocrinology of the opioids.

  Mark J. Millan;Albert Herz

  244
  Citations

• Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. II. Agonist and antagonist properties at subtypes of dopamine D(2)-like receptor and alpha(1)/alpha(2)-adrenoceptor.

  Adrian Newman-Tancredi;Didier Cussac;Valérie Audinot;Jean-Paul Nicolas

  237
  Citations

• Stress-induced release of brain and pituitary beta-endorphin: major role of endorphins in generation of hyperthermia, not analgesia.

  M.J. Millan;R. Przewlock;M. Jerlicz;Ch. Gramsch

  222
  Citations

• Selective Blockade of Dopamine D3 Receptors Enhances while D2 Receptor Antagonism Impairs Social Novelty Discrimination and Novel Object Recognition in Rats: A Key Role for the Prefrontal Cortex

  David J G Watson;Florence Loiseau;Manuela Ingallinesi;Mark J Millan

  203
  Citations

• Potentiation of the Fluoxetine-Induced Increase in Dialysate Levels of Serotonin (5-HT) in the Frontal Cortex of Freely Moving Rats by Combined Blockade of 5-HT1A and 5-HT1B Receptors with WAY 100,635 and GR 127,935

  A Gobert;J M Rivet;L Cistarelli;M J Millan

  190
  Citations

• Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the 'atypical' antipsychotics, clozapine and risperidone

  Rudy Schreiber;Mauricette Brocco;Mark J. Millan

  189
  Citations

• S33084, a novel, potent, selective, and competitive antagonist at dopamine D(3)-receptors: I. Receptorial, electrophysiological and neurochemical profile compared with GR218,231 and L741,626.

  Mark J. Millan;Alain Gobert;Adrian Newman-Tancredi;Françoise Lejeune

  176
  Citations

• Clozapine is a partial agonist at cloned, human serotonin 5-HT1A receptors.

  A. Newman-Tancredi;C. Chaput;L. Verriele;M.J. Millan

  169
  Citations

• S33005, a novel ligand at both serotonin and norepinephrine transporters: II. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.

  Millan Mj;Dekeyne A;Papp M;La Rochelle Cd

  165
  Citations

• Expanding the repertoire of L-DOPA’s actions: A comprehensive review of its functional neurochemistry

  Philippe De Deurwaerdère;Giuseppe Di Giovanni;Giuseppe Di Giovanni;Mark J. Millan

  145
  Citations

• α2‐Adrenergic Receptor Blockade Markedly Potentiates Duloxetine‐ and Fluoxetine‐Induced Increases in Noradrenaline, Dopamine, and Serotonin Levels in the Frontal Cortex of Freely Moving Rats

  A Gobert;J M Rivet;L Cistarelli;C Melon

  145
  Citations

• Induction of burst firing in ventral tegmental area dopaminergic neurons by activation of serotonin (5-HT)1A receptors: WAY 100,635-reversible actions of the highly selective ligands, flesinoxan and S 15535.

  Françoise Lejeune;Mark J. Millan

  143
  Citations

• (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.

  Unknown

  120
  Citations